Warianty tytułu
Co znajduje się w najnowszym kremie?
Języki publikacji
Abstrakty
The results of research carried out by many research centres throughout the world in the past few years have opened a wide range of new opportunities and technological solutions for the cosmetic industry. It became possible to increase the number of various active .components with a specific spectrum of activity on particular metabolic mechanisms and particular skin structures. In this work we present several examples of latest breakthroughs in global cosmetology and forms an attempt at illustrating the trends on the cosmetic market for the years to come.(original abstract)
Wyniki prac badawczych wielu ośrodków naukowych na całym świecie w ostatnich kilku latach otworzyły dla przemysłu kosmetycznego szereg nowych możliwości i rozwiązań technologicznych. Możliwe stało się również rozszerzenie gamy składników aktywnych o specyficznym spektrum działania na konkretne mechanizmy metaboliczne i konkretne struktury skóry. W niniejszej pracy przedstawiono przykłady najnowszych osiągnięć światowej kosmetologii oraz poczyniona zostanie próba zarysowania trendów w przemyśle kosmetycznym jakie rysują się na najbliższe kilka lat. (abstrakt oryginalny)
Twórcy
autor
Bibliografia
- [l] Tran K.T., Lamb P., Deng J.S. (2005) Matrikines and matricryptins: Implications for cutaneous cancers and skin repair. J. Dermatol. Sei., Oct., 40 (1), 11-20.
- [2] Maquart F.X., Bellon G., Pasco S., Monboisse J.C. (2005) Matrikines in the regulation of extracellular matrix degradation. Biochimie. 87 (3-4), 353-360.
- [3] Duca L., Floquet N., Alix A.J., Haye В., Debelle L. (2004) Elastin as a matrikine. Crit. Rev. Oncol. Hematol., 49 (3), 235-244.
- [4] Maquart F.X., Pasco S., Ramont L., Hornebeck W., Monboisse J.C. (2004) An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit. Rev. Oncol. Hematol., 49 (3), 199-202.
- [5] Maquart F.X., Simeon A., Pasco S., Monboisse J.C. (1999) Regulation of cell activity by the extracellular matrix: the concept of matrikines. J. Soc. Biol, 193 (4-5), 423-428.
- [6] Materials by Pentapharm Company
- [7] McCracken M.S., Khan J.A., Wulc A.E., et al. (2006) Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr. Surg., 22(3), 188-191.
- [8] Matarasso S.L., Carrathers J.D., Jewell M.L. (2006) Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr. Surg., 117 (3 Suppl):3S-34S; discussion 35S-43S.
- [9] DeLorenzi C., Weinberg M., Solish N., et al. (2006) Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report. Dermatol. Surg., 32 (2), 205-211.
- [10] Carruthers J., Klein A.W., Carrathers A., et al. (2005) Facial sculpting and tissue augmentation. Dermatol. Surg., 31 (3), 276-280.
- [11] Andre P. (2004) Hyaluronic acid and its use as a "rejuvenation" agent in cosmetic dermatology. Semin. Cutan. Med. Surg., 23( 4), 218-222.
- [12] Tan S.W., Johns M.R., Greenfield P.P. (1990) Hyaluronic acid - a versatile biopolymer. Aust. J. Biotechnol., 4 (1), 38-43.
- [13] Guy R.H., Potts R.O. (1992) Structure-permeability relationships in percutaneous absorption. J. Pharm. Sci., 81, 603-604.
- [14] Materials by Coletica Company
- [15] Bertossi D., Zancanaro C., Trevisiol L., et al. (2003) Lipofilling of the lips: ultrastructural evaluation by transmission electron microscopy of injected adipose tissue.", Arch. Facial Plast. Surg., 5 (5), 392-398.
- [16] von Heimburg D., Pallua N. (2001) Two-year histological outcome of facial lipofilling. Ann. Plast. Surg., 46 (6), 644-646.
- [17] Materials by Silab Company
- [18] Materials by Alban Muller Company
- [19] Own research by DERMIKA Sp. z o.o., Poland
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.ekon-element-000160065170